The U.S. Food and Drug Administration (FDA) has approved updated Covid-19 vaccines, but this time for a more restricted audience: primarily adults aged 65 and older and younger individuals deemed at higher risk for severe illness from the virus.
According to Robert F. Kennedy Jr., the U.S. Health and Human Services Secretary, the updated vaccines from Moderna (for those 6 months and older), Pfizer (for those 5 and older), and Novavax (for those 12 and older) will be available to patients after consulting with their healthcare providers. However, this decision may significantly limit access to Covid-19 vaccinations, particularly for infants and young children, who are considered especially vulnerable to the virus.
Last respiratory virus season, there were 48 Covid-19 hospitalizations for every 100,000 children under the age of 5, a rate nearly seven times greater than that of older children and more than double that of adults under 50. As part of the recent changes, emergency use authorizations for the vaccines have been rescinded, meaning that Pfizer’s Covid-19 vaccine is no longer available for children younger than 5. Moderna’s vaccine is approved for children as young as 6 months, but only if they have an underlying condition that puts them at greater risk.
Critics, including Fatima Khan, co-founder of the nonprofit group Protect Their Future, have voiced concerns over the FDA’s decision, arguing that it limits essential vaccine access for young children. Khan stated, “By restricting access to safe, evidence-based vaccines, federal leaders are choosing ideology over science.”
In contrast, the American Academy of Pediatrics has recently recommended Covid-19 vaccinations for infants and young children, diverging from guidance provided by the Centers for Disease Control and Prevention (CDC), which no longer recommends vaccines for healthy children or pregnant women. The CDC’s updated immunization schedule allows for vaccines to be administered after consultation with healthcare providers.
Covid-19 cases have been on the rise across the United States, with increasing transmission rates reported in most states. Current data suggests that virus levels are about half of what they were during the peak of last summer’s surge, but they match the levels seen during the summer of 2023, indicating a potential upward trend in cases in the coming weeks.
This breaking news story will continue to be updated as more information becomes available. For further updates on health news and Covid-19 developments, stay connected with hiphopraisedmetheblog.com.
